Author:

CHDS faculty Lisa A. Robinson and James K. Hammitt, and research staff Lucy O’Keeffe, recently published “Valuing Mortality Risk Reductions in Global Benefit-Cost Analysis.”

The CHDS Media Hub team continues its ongoing mission to improve multi-modal pedagogy across the Harvard Chan School through a new partnership between Media Hub Director Jacob Waxman

Natalia Kunst, PhD candidate at the University of Oslo, presented a CHDS lunchtime seminar on “What is the Value of Further Research on the 21-Gene Assay for Breast Cancer Management”.

We proudly announce CHDS affiliated faculty members’ recognition for their outstanding work in medical decision making. The Society for Medical Decision Making awarded

The Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts Medical Center announces its call for submissions for the inaugural CEVR Cost-Effectiveness Analysis (CEA)

Dr. James Hammitt, Professor of Economics and Decision Sciences and Director of the Harvard Center for Risk Analysis, marks 25 years of teaching, research, and service at Harvard University.

The Society for Benefit-Cost Analysis offers its inaugural Outstanding Dissertation Award to recognize an outstanding PhD thesis dealing with the theory and/or practice

The EPIC project convened a group of technical advisors at CHDS to provide feedback on the project’s work streams. Over 20 participants included experts in immunization, costing, and economics

CHDS visitor and Williams College student David Krane spoke at the CHDS lunchtime seminar series on “Using Simulation to Improve Machine Learning of Complex Systems”.

Rowan Iskandar, PhD, presented a novel theoretical framework for Markov cohort models at a CHDS research seminar. Markov cohort models are commonly used in decision analysis to model